论文部分内容阅读
目的分析天津市高血压患者死亡特征,为制定高血压防治对策提供依据。方法依照疾病和有关健康问题的国际统计疾病分类第10次修订本(ICD-10)对疾病进行编码,用根本死因进行统计分类,对天津市2015年户籍居民死因资料中高血压患者死亡情况进行统计分析。统计分析采用SPSS 15.0软件包,以χ~2检验进行率的比较。结果天津市高血压患者死亡13 608例,占总死亡数的18.56%,高血压死亡率为132.52/10万,标化死亡率为330.57/10万,其中男性粗死亡率为141.03/10万,标化死亡率为362.22/10万,女性死亡率为123.95/10万,标化死亡率为296.93/10万,男性高于女性;高血压患者第1位死亡原因为脑血管病,占高血压死亡的57.02%,第2位为心脏病,占30.38%;,与非高血压患者相比,高血压患者院外死亡的比例更高,是非高血压患者的3.59倍,院外死亡中死于脑血管病的比例为92.1%。结论脑血管疾病是高血压患者最主要的死亡原因,在规范治疗高血压的同时,要进一步强化预防高血压发生的危险因素,减少患者心脑血管事件的发生。
Objective To analyze the characteristics of death in hypertensive patients in Tianjin and provide the evidence for the prevention and treatment of hypertension. Methods The disease was coded according to the 10th revised edition of International Statistical Classification of Diseases (ICD-10) on diseases and related health issues, and the statistical classification was made on the basis of the cause of death. Statistics were made on the deaths of hypertensive patients in the cause of death data of 2015 registered permanent residents in Tianjin analysis. Statistical analysis using SPSS 15.0 software package, to χ ~ 2 test rate comparison. Results Thirteen 138 cases of hypertensive patients died in Tianjin, accounting for 18.56% of the total number of deaths, the mortality rate of hypertension was 132.52 / 100000, the standardized mortality rate was 330.57 / 100000, of which the male crude death rate was 141.03 / The standardized death rate was 362.22 / lakh, the female mortality rate was 123.95 / lakh and the standardized mortality rate was 296.93 / lakh, which was higher in males than in females; the first cause of death in hypertensive patients was cerebrovascular disease, accounting for hypertension 57.02% of deaths, the second was heart disease, accounting for 30.38%; compared with non-hypertensive patients, the proportion of hypertensive patients died of hypertension was 3.59 times higher than that of non-hypertensive patients, died of cerebrovascular disease The proportion of sick was 92.1%. Conclusions Cerebrovascular disease is the most important cause of death in patients with hypertension. While standardizing the treatment of hypertension, we should further strengthen the risk factors for preventing hypertension and reduce the occurrence of cardiovascular and cerebrovascular events in patients.